Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Journal of Neuropathology and Experimental Neurology|June 8, 2018
Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic XanthoastrocytomaEric M Thompson, Michael Brown, Elena Dobrikova, et al.Science Translational Medicine|September 22, 2017
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLsMichael C Brown, Eda K Holl, David Boczkowski, et al.Oncotarget|November 3, 2016
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft modelsEda K Holl, Michael C Brown, David Boczkowski, et al.Virology|December 31, 2003
The double-stranded RNA-activated protein kinase mediates viral-induced encephalitisDonalyn Scheuner, Matthias Gromeier, Monique V Davies, et al.Neuro-Oncology|March 3, 2023
Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNSYuanfan Yang, Michael C Brown, Gao Zhang, et al.Archives of Pathology & Laboratory Medicine|August 23, 2017
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant GliomasVidyalakshmi Chandramohan, Jeffrey D Bryant, Hailan Piao, et al.Nature Communications|January 29, 2020
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunityMubeen M Mosaheb, Elena Y Dobrikova, Michael C Brown, et al.Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.Journal for Immunotherapy of Cancer|April 18, 2023
Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophilsMichael C Brown, Georgia M Beasley, Zachary P McKay, et al.Journal for Immunotherapy of Cancer|May 31, 2019
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinationsVidyalakshmi Chandramohan, Xuhui Bao, Xin Yu, et al.Pageof 9